Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/24297
Title: | The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases |
Authors: | Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı. Eker, Salih Saygın Sarandol, Aslı Akkaya, Cengiz Sivrioğlu, Enver Yusuf Kırlı, Selçuk Q-9477-2019 14019347700 14020405100 14061855100 14062563200 14019745700 |
Keywords: | Antipsychotic QTc prolongation Ziprasidone Torsade-de-pointes Schizoaffective disorder Antipsychotic-drugs Acute exacerbation Double-blind 160 mg/day Schizophrenia Safety Haloperidol Management Neurosciences & neurology Pharmacology & pharmacy Psychiatry |
Issue Date: | Nov-2009 |
Publisher: | Sage Publications |
Citation: | Eker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996. |
Abstract: | QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment. |
URI: | https://doi.org/10.1177/0269881108093843 https://journals.sagepub.com/doi/10.1177/0269881108093843 http://hdl.handle.net/11452/24297 |
ISSN: | 0269-8811 |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.